Navellier & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-19,196
| Closed | -$1.21M | – | 286 |
|
|
2020
Q3 | $1.21M | Sell |
19,196
-38,379
| -67% | -$2.43M | 0.26% | 97 |
|
|
2020
Q2 | $4.43M | Buy |
57,575
+20,531
| +55% | +$1.58M | 1.05% | 27 |
|
|
2020
Q1 | $2.77M | Buy |
+37,044
| New | +$2.77M | 0.65% | 38 |
|
|
2016
Q2 | – | Sell |
-15,819
| Closed | -$1.45M | – | 257 |
|
|
2016
Q1 | $1.45M | Sell |
15,819
-1,055
| -6% | -$96.9K | 0.19% | 71 |
|
|
2015
Q4 | $1.71M | Sell |
16,874
-2,052
| -11% | -$208K | 0.19% | 60 |
|
|
2015
Q3 | $1.86M | Sell |
18,926
-28
| -0.1% | -$2.75K | 0.19% | 61 |
|
|
2015
Q2 | $2.22M | Buy |
18,954
+311
| +2% | +$36.4K | 0.19% | 67 |
|
|
2015
Q1 | $1.83M | Buy |
18,643
+5,752
| +45% | +$564K | 0.17% | 73 |
|
|
2014
Q4 | $1.22M | Sell |
12,891
-1,297
| -9% | -$122K | 0.06% | 94 |
|
|
2014
Q3 | $1.51M | Buy |
14,188
+10,571
| +292% | +$1.13M | 0.08% | 69 |
|
|
2014
Q2 | $300K | Sell |
3,617
-168
| -4% | -$13.9K | 0.01% | 253 |
|
|
2014
Q1 | $268K | Sell |
3,785
-31,228
| -89% | -$2.21M | 0.01% | 271 |
|
|
2013
Q4 | $2.63M | Sell |
35,013
-4,456
| -11% | -$335K | 0.12% | 41 |
|
|
2013
Q3 | $2.48M | Buy |
39,469
+17,960
| +83% | +$1.13M | 0.07% | 73 |
|
|
2013
Q2 | $1.1M | Buy |
+21,509
| New | +$1.1M | 0.05% | 102 |
|